Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN6G in Geographic Atrophy Secondary to AMD
NCT01577381Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2012
- Primary completion
- Sep 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of RN6G in geographic atrophy (GA), sponsored by Pfizer. Started Aug 2012; status: terminated.
02
Drugs
RN6G
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01577381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577381.